Nutritional Status and Dietary Intakes of The Patients With Mild-To-Moderate Alzheimer's Disease

被引:0
|
作者
Fernando, Malika [1 ]
Marliya, Thasmeeha [2 ]
Raeesa, Fathima [2 ]
Williams, Shehan [1 ]
Silva, Renuka [2 ]
机构
[1] Univ Kelaniya, Fac Med, Dept Psychiat, Colombo, Sri Lanka
[2] Wayamba Univ Sri Lanka, Fac Livestock Fisheries & Nutr, Dept Appl Nutr, Kuliyapitiya, Sri Lanka
关键词
Alzheimer's Disease; Nutritional status; Dietary intakes; Micronutrients;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
828
引用
收藏
页码:294 / 294
页数:1
相关论文
共 50 条
  • [31] Y Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
    Ballard, Clive
    Atri, Alireza
    Boneva, Neli
    Cummings, Jeffrey L.
    Froelich, Lutz
    Luis Molinuevo, Jose
    Tariot, Pierre N.
    Raket, Lars Lau
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 164 - 174
  • [32] Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
    Kim, Seong Yoon
    Choi, Seong Hye
    Rollema, Hans
    Schwam, Elias M.
    McRae, Tom
    Dubrava, Sarah
    Jacobsen, Janice
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2014, 37 (3-4) : 232 - 245
  • [33] Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease
    Griffith, Patrick
    Lichtenberg, Peter
    Goldman, Robert
    Payne-Parrish, Jennifer
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (10) : 1590 - 1597
  • [34] Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
    Marina Ritchie
    Daniel L. Gillen
    Joshua D. Grill
    Alzheimer's Research & Therapy, 15
  • [35] Health-related quality of life in community dwelling patients with mild-to-moderate Alzheimer's disease
    Raggi, A.
    Tasca, D.
    Capra, P. M. D. Lupica
    Panerai, S.
    Neri, W.
    Ferri, R.
    EUROPEAN GERIATRIC MEDICINE, 2017, 8 (02) : 158 - 163
  • [36] Significant behavioral benefits with continued donepezil treatment in patients with mild-to-moderate Alzheimer's disease.
    Nunez, M
    Barcikowska, M
    Dautzenberg, P
    Heun, R
    Jakobsen, S
    Karageorgiou, C
    Triau, E
    Tury, F
    Qvitzau, S
    Richardson, S
    Xu, Y
    Schwam, E
    Schindler, R
    Johannsen, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S76 - S76
  • [37] The Effect of Memantine on Cognitive Function and Behavioral and Psychological Symptoms in Mild-to-Moderate Alzheimer's Disease Patients
    Zhang, Nan
    Wei, Changjuan
    Du, Hongjian
    Shi, Fu-Dong
    Cheng, Yan
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 40 (1-2) : 85 - 93
  • [38] Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians
    del Campo, Natalia
    Cesari, Matteo
    Canevelli, Marco
    Hoogendijk, Emiel O.
    Lilamand, Matthieu
    Kelaiditi, Eirini
    Soto, Maria E.
    Ousset, Pierre-Jean
    Weiner, Michael W.
    Andrieu, Sandrine
    Vellas, Bruno
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (10) : 913 - 920
  • [39] Structural Correlates of Overt Sentence Reading in Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease
    De Looze, Celine
    Dehsarvi, Amir
    Suleyman, Narin
    Crosby, Lisa
    Hernandez, Belinda
    Coen, Robert F. F.
    Lawlor, Brian A. A.
    Reilly, Richard B. B.
    CURRENT ALZHEIMER RESEARCH, 2022, 19 (08) : 606 - 617
  • [40] Safety and tolerability of GRF6019 in mild-to-moderate Alzheimer's disease dementia
    Hannestad, Jonas
    Koborsi, Katie
    Klutzaritz, Vicki
    Chao, Whitney
    Ray, Rebecca
    Paez, Antonio
    Jackson, Sam
    Lohr, Scott
    Cummings, Jeffrey L.
    Kay, Gary
    Nikolich, Karoly
    Braithwaite, Steven
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)